ulcers on cervix uteri

Comparative study of a Unani formulation and Cryotherapy in women with cervical ectropion

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/038178

Enrollment

Registered

2021-11-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N86- Erosion and ectropion of cervix uteri Health Condition 2: N86- Erosion and ectropion of cervix uteri

Interventions

Intervention1: â?¢Murr (Commiphora myrrha), â?¢Safeda (Lead carbonate), â?¢Anzaroot (Astragalus sarcocola), â?¢Mom (Beeswax) and â?¢Roghane gul (Rose oil) : Method of preparation, dosage & route o

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of cervical ectropion. Normal or inflammatory changes in pap smear. Premalignant lesion of cervix (CIN-1)

Exclusion criteria

Exclusion criteria: Patients with • CIN- II, III & cervical malignancy. • Acute PID, STDâ??s, DM, HTN. • OC Pills & IUCDâ??s. • Pregnant & lactating women.

Design outcomes

Primary

Measure	Time frame
healing of cervical lesionTimepoint: At baseline, 4 weeks, 8 weeks	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Ismath Shameem

National Institute of Unani Medicine

dr.ismaths@gmail.com9449977008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026